December 19, 2008

"I am HCL - Axon": HCL – Axon Deal Dissected

Dear All,

On December 15, 2008, the website of HCL Technologies Limited (“HCL”) was promptly changed to proudly mention “I am HCL Axon”, immediately after the High Court of Justice in England and Wales confirmed the approval of the ‘scheme of arrangement’ for the acquisition of the Surrey (UK) based Axon Group plc in an all cash deal worth GBP 441 million to be paid to its shareholders by HCL’s UK based indirect wholly owned subsidiary, HCL EAS Limited.

HCL’s acquisition of Axon, in a worsening business environment worldwide, puts ambitious India Inc. in global limelight yet again. The deal which adds to the acquisition blitzkrieg by Indian Inc. intensifies the shift of balance of power and raises the question – has the age of reverse colonization really arrived?

Please click here for the document, for a detailed dissection of not only the Indian and UK legal, tax and regulatory aspects, but also the commercial viability of this historic acquisition for HCL which clearly is – the largest acquisition in the tech space ever by any Indian company overseas.

As you would be aware, we have been providing regular information on latest legal developments. M&A Lab is our latest initiative to provide you in depth and knowledge based analysis of latest M&A deals. We will be happy to have your views / comments on our initiative. Please read the disclaimer carefully

 

 

 


 Team M&A
 Sambhav Ranka / Ruchir Sinha / Nishchal Joshipura
You can direct your queries or comments to Team M&A
 

Welcome to connect with us at interesting conferences, seminars and events (more...

 
  VIDEO
Vyapak Desai on FII, FDI norms
Kartik Ganapathy on Ranbaxy Daiichi deal
Nishith Desai on Vodafone Controversy
Siddharth Shah on P Notes
 
M&A Lab
Zandu - Emami Hostile Turned Friendly M&A Deal Dissected, December 3, 2008
Ranbaxy - Daiichi Deal Dissected, November 14, 2008
 
  ARTICLES, HOTLINES & RESEARCH REPORTS
SEBI goes the distance in easing takeover regulations, The Economic Times, Ruchir Sinha & Nishchal Joshipura, November 11, 2008
Is it time to bid adieu to ‘poison pills’? The Economic Times, R Vaidhyanadhan Iyer & Nishchal Joshipura, May 27, 2008
Amendments To Takeover Code – Oversight Or Intended?, November 7, 2008 
Mergers & Acquisitions in India  
Venture Capital at Crossroads
 
  SUBSCRIPTION

We update our clients by sending various hotlines. You can subscribe to one / more hotlines also. You can email us for registering yourself for any of the hotlines given below.

Corpsec Hotline
Tax Hotline
HR Hotline
iCe Hotline
Annual Budget
FII Hotline
Pharma Update
Infra Update
IP Update
Dispute Resolution Hotline


Unsubscribe
Feedback





Disclaimer: The contents of this hotline should not be construed as legal opinion. View detailed disclaimer.

This M&A Lab provides general information existing at the time of preparation. The M&A Lab is intended as a news update and Nishith Desai Associates neither assumes nor accepts any responsibility for any  loss arising to any person acting or refraining from acting as a result of any material contained in this M&A Lab. It is recommended that professional advice be taken based on the specific facts and circumstances. This M&A Lab does not substitute the need to refer to the original pronouncements. 

This is not a Spam mail. You have received this mail because you have either requested for it or someone must have suggested your name. Since India has no anti-spamming law, we refer to the US directive, which states that a mail cannot be considered Spam if it contains the sender's contact information, which this mail does. In case this mail doesn't concern you, please unsubscribe from mailing list.